Exploring the efficacy of novel photobactericidals against planktonic and biofilm growing uropathogenic bacteria
探索新型光杀菌剂对浮游和生物膜生长的尿路致病菌的功效
基本信息
- 批准号:388056781
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:德国
- 项目类别:Research Grants
- 财政年份:2018
- 资助国家:德国
- 起止时间:2017-12-31 至 2021-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Worldwide thousands of patients suffer from urinary tract infection (UTI). Current treatments of UTI are commonly based on high concentration of systemically applied antibiotics. A disadvantage in this treatment lies in the promoted development of (multi)resistances. Antimicrobial photodynamic therapy is alternative, non-antibiotic based treatment method that allows us to meet current challenges in a very effective way; it does not lead to the selection of resistant mutants and can destroy pathogens in a short time frame by the combined action of a photosensitizer and near infrared light. The selective and specific binding of photosensitizer to lipopolysaccharides as particularly attractive targets is envisaged, complementing our previous work on the search for PSs that might be considered good candidates for the photoinactivation of Gram-negative bacteria. We aim to modulate the chemical structure of photosensitizers so that they can be rapidly taken up by Gram-negative bacteria at low concentrations and kill microorganisms but not damage the host tissue. The proteomic analysis will be used to increase our insight into the sequential steps by which microorganisms are photoinactivated. The resistance of bacterial biofilms against antibiotic treatment is one of the major reasons why those who get UTI are highly susceptible to getting more in the future. In this project, we aim to disperse formed biofilms upon photodynamic action. In addition, we will use the photosensitizers for the development of innovative, self-regulated coatings to prevent and treat catheter-associated urinary tract infections. Photocytotoxic characteristics of photosensitizers and model surfaces against a range of clinically important Gram-negative bacteria will be determined.
全世界成千上万的患者患有尿路感染(UTI)。目前UTI的治疗通常基于高浓度的全身应用的抗生素。这种处理的缺点在于促进了(多)抗性的发展。抗微生物光动力疗法是一种替代的、非抗生素的治疗方法,使我们能够以非常有效的方式应对当前的挑战;它不会导致选择耐药突变体,并且可以通过光敏剂和近红外光的联合作用在短时间内摧毁病原体。设想光敏剂与脂多糖作为特别有吸引力的靶点的选择性和特异性结合,补充了我们以前在寻找PS上的工作,PS可能被认为是革兰氏阴性菌光灭活的良好候选者。 我们的目标是调节光敏剂的化学结构,使它们可以在低浓度下迅速被革兰氏阴性菌吸收,杀死微生物,但不损害宿主组织。蛋白质组学分析将用于增加我们对微生物被光灭活的顺序步骤的了解。细菌生物膜对抗生素治疗的耐药性是那些UTI患者在未来极易患上更多UTI的主要原因之一。在这个项目中,我们的目标是分散光动力作用形成的生物膜。此外,我们将使用光敏剂开发创新的自我调节涂层,以预防和治疗导管相关的尿路感染。将确定光敏剂和模型表面对一系列临床上重要的革兰氏阴性菌的光细胞毒性特征。
项目成果
期刊论文数量(12)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Facile Fabrication of Silicon(IV)Phthalocyanine-Embedded Poly(vinyl alcohol)-Based Antibacterial and Antifouling Interfaces.
- DOI:10.1021/acsabm.0c00347
- 发表时间:2020-05
- 期刊:
- 影响因子:4.7
- 作者:Konstantin Strokov;A. Schäfer;U. Dobrindt;A. Galstyan
- 通讯作者:Konstantin Strokov;A. Schäfer;U. Dobrindt;A. Galstyan
Biodegradable supramolecular micelles via host-guest interaction of cyclodextrin-terminated polypeptides and adamantane-terminated polycaprolactones.
- DOI:10.1039/d1cc03372g
- 发表时间:2021-09
- 期刊:
- 影响因子:4.9
- 作者:Sharafudheen Pottanam Chali;Suna Azhdari;A. Galstyan;André H. Gröschel;B. Ravoo
- 通讯作者:Sharafudheen Pottanam Chali;Suna Azhdari;A. Galstyan;André H. Gröschel;B. Ravoo
Chitosan‐Silicon Phthalocyanine Conjugate as Effective Photo‐Functional Hydrogel for Tracking and Killing of Bacteria
- DOI:10.1002/ejoc.202001363
- 发表时间:2020-10
- 期刊:
- 影响因子:2.8
- 作者:Konstantin Strokov;A. Galstyan
- 通讯作者:Konstantin Strokov;A. Galstyan
Influence of photosensitizer concentration and polymer composition on photoinduced antimicrobial activity of PVA- and PVA-chitosan-based electrospun nanomaterials cross-linked with tailor-made silicon(IV) phthalocyanine
- DOI:10.1007/s43630-022-00229-9
- 发表时间:2022-05
- 期刊:
- 影响因子:3.1
- 作者:A. Galstyan;Konstantin Strokov
- 通讯作者:A. Galstyan;Konstantin Strokov
Dye extract of calyces of Hibiscus sabdariffa has photodynamic antibacterial activity: A prospect for sunlight‐driven fresh produce sanitation
- DOI:10.1002/fsn3.1580
- 发表时间:2020-04
- 期刊:
- 影响因子:3.9
- 作者:Hussaini Majiya;A. Galstyan
- 通讯作者:Hussaini Majiya;A. Galstyan
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Professorin Dr. Anzhela Galstyan其他文献
Professorin Dr. Anzhela Galstyan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Professorin Dr. Anzhela Galstyan', 18)}}的其他基金
Antibacterial activity of light triggered antibiotics against uropathogenic bacteria
光引发抗生素对尿路致病菌的抗菌活性
- 批准号:
299246075 - 财政年份:2016
- 资助金额:
-- - 项目类别:
Research Grants
Multifunctional photoactive nanocarriers for degradation of bacterial biofilms
用于降解细菌生物膜的多功能光活性纳米载体
- 批准号:
531205207 - 财政年份:
- 资助金额:
-- - 项目类别:
Research Grants
相似国自然基金
噬菌体靶向肠道粪肠球菌提高帕金森病左旋多巴疗效的机制研究
- 批准号:82371251
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
新型小分子蛋白—人肝细胞生长因子三环域(hHGFK1)抑制破骨细胞及治疗小鼠骨质疏松的疗效评估与机制研究
- 批准号:82370885
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
HER2特异性双抗原表位识别诊疗一体化探针研制与临床前诊疗效能研究
- 批准号:82372014
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
相似海外基金
Exploring, Predicting, and Intervening on Long-term Viral suppression Electronically (EPI-LoVE)
电子方式探索、预测和干预长期病毒抑制 (EPI-LoVE)
- 批准号:
10676683 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Exploring Small Molecule Inhibitors of PAF1C as Novel HIV Latency Reversal Agents
探索 PAF1C 小分子抑制剂作为新型 HIV 潜伏期逆转剂
- 批准号:
10762258 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Exploring mechanisms underlying SCF+G-CSF-enhanced recovery in chronic TBI.
探索 SCF G-CSF 增强慢性 TBI 恢复的潜在机制。
- 批准号:
10741338 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Exploring p53-mediated ferroptosis to treat IDH1-mutant glioma
探索 p53 介导的铁死亡治疗 IDH1 突变神经胶质瘤
- 批准号:
10588005 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Exploring novel modulators for rescuing cigarette smoke-induced corneal edema and examining iPSC-derived corneal endothelial cells as a treatment modality
探索新型调节剂来挽救香烟烟雾引起的角膜水肿并检查 iPSC 衍生的角膜内皮细胞作为治疗方式
- 批准号:
10723408 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Exploring novel therapeutic strategies for combinatory therapy to treat renal clear cell carcinomas
探索联合治疗肾透明细胞癌的新治疗策略
- 批准号:
10608244 - 财政年份:2023
- 资助金额:
-- - 项目类别:
A Chemical Genetic Approach to Exploring Novel Therapeutic Space for Colorectal Cancer
探索结直肠癌新治疗空间的化学遗传学方法
- 批准号:
10908073 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Exploring the Potential of Natural Products to Combat COVID-19
探索天然产品对抗 COVID-19 的潜力
- 批准号:
10696937 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Exploring the modulation of synaptic/extrasynaptic NMDAR balance as a novel therapeutic strategy in Alzheimer's disease and other neurodegenerations
探索突触/突触外 NMDAR 平衡的调节作为阿尔茨海默病和其他神经退行性疾病的新型治疗策略
- 批准号:
10655316 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Exploring the physicochemical properties governing compound efflux in Gram-negative bacteria
探索革兰氏阴性菌中控制化合物流出的理化特性
- 批准号:
10543743 - 财政年份:2022
- 资助金额:
-- - 项目类别: